You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 63 No. 2, February 2006 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (13)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Neuroendocrinology
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

What's in a NAIM?

Hashimoto Encephalopathy, Steroid-Responsive Encephalopathy Associated With Autoimmune Thyroiditis, or Nonvasculitic Autoimmune Meningoencephalitis?

Arch Neurol. 2006;63:175-176.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Hashimoto encephalopathy was first described by Lord Brain in 1966.1 Multiple case reports followed and the term Hashimoto encephalopathy became generally accepted for the syndrome of encephalopathy in association with Hashimoto thyroiditis. Although Brain's original patient with Hashimoto encephalopathy did not improve with corticosteroid treatment, most of the patients described later showed marked improvement with some form of immunosuppression. This has led to the renaming of Hashimoto encephalopathy by some authors as "steroid-responsive encephalopathy associated with autoimmune thyroiditis" (SREAT)2 or "nonvasculitic autoimmune meningoencephalitis" (NAIM), a heterogeneous group that would include autoimmune disorders such as Sjögren syndrome and systemic lupus erythematosus–associated meningoencephalitis as well as Hashimoto encephalopathy. These disorders are unified by the feature of steroid responsiveness.3

The debate over terminology and classification of Hashimoto encephalopathy revolves around 2 issues: (1) Do thyroid antibodies have any significance in this disorder? (2) Is steroid responsiveness a clinical feature that can define this . . . [Full Text of this Article]

AUTHOR INFORMATION

Ji Y. Chong, MD; Lewis P. Rowland, MD



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Steroid-Responsive Encephalopathy Associated With Autoimmune Thyroiditis
Pablo Castillo, Bryan Woodruff, Richard Caselli, Steven Vernino, Claudia Lucchinetti, Jerry Swanson, John Noseworthy, Allen Aksamit, Jonathan Carter, Joseph Sirven, Gene Hunder, Vahab Fatourechi, Bahram Mokri, Daniel Drubach, Sean Pittock, Vanda Lennon, and Brad Boeve
Arch Neurol. 2006;63(2):197-202.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.